Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

Journal of Clinical Oncology

Volumn 27, Issue 10, 2009, Pages 1572-1578

  Schefter, Tracey E ^a   Rusthoven, Kyle E ^a   Kavanagh, Brian D ^a   Cardenes, Higinia ^a   Stieber, Volker W ^a   Burri, Stuart H ^a   Feigenberg, Steven J ^a   Chidel, Mark A ^a   Pugh, Thomas J ^a   Franklin, Wilbur ^a   Kane, Madeleine ^a   Gaspar, Laurie E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; NARCOTIC ANALGESIC AGENT; PANITUMUMAB; ANTIBIOTIC AGENT; DOXORUBICIN; IFOSFAMIDE; IMATINIB;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; LIVER DISEASE; LIVER METASTASIS; PAIN; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; SOFT TISSUE INJURY; STEREOTACTIC BODY RADIATION THERAPY; THROMBOSIS; ANTIBIOTIC THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; LUNG METASTASIS; LUNG TOXICITY; MULTIPLE CYCLE TREATMENT; PERIPHERAL LUNG LESION; RADIATION DERMATITIS; RADIATION PNEUMONIA; RESPIRATORY FAILURE; SARCOMA; TREATMENT RESPONSE; VIRUS PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; LUNG NEOPLASMS;

EID: 63749100778     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.6329     Document Type: Article

References (26)

1. Jackson A, Ten Haken RK, Robertson JM, et al: Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31:883-891, 1995
2. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK: Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53(4):810- 821, 2002
3. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-318, 1999
4. Shah SA, Bromberg R, Coates A, et al: Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 205:676-683, 2007
5. Aloia TA, Vauthey JN, Loyer EM, et al: Solitary colorectal liver metastasis: Resection determines outcome. Arch Surg 141:460-466, 2006
6. Herfarth KK, Debus J, Lohr F, et al: Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 19:164-170, 2001
7. Herfarth KK, Debus J: Stereotactic radiation therapy for liver metastases. Chirurg 76:564-569, 2005
8. McCammon R, Schefter TE, Gaspar LE, et al: Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 73:112-118, 2009
9. McGarry RC, Papiez L, Williams M, et al: Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63:1010-1015, 2005
10. Yamada Y, Bilsky MH, Lovelock DM, et al: High-dose, single-fraction image-guided intensity- modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71:484-490, 2008
11. Schefter TE, Kavanagh BD, Timmerman RD, et al: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371-1378, 2005
12. Kavanagh BD, Schefter TE, Cardenes HR, et al: Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45:848-855, 2006
13. Penna C, Nordlinger B: Colorectal Metastasis (liver and lung). Surg Clin North Am 82:1075-1090, 2002
14. Russell AH, Clyde C, Wasserman TH, et al: Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 27:117-123, 1993
15. Fowler JF: The Linear-quadratic formula and progress in fractionated radiotherapy: A review. Br J Radiol 62:679-694, 1989
16. Herfarth KK, Hof H, Bahner ML, et al: Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444-451, 2003
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Cox DR: Regression models and life-tables. J R Stat Soc 34:187-202, 1972
19. Hashemi R, Comenges D: Correction of the p-value after multiple tests in a Cox proportional hazard model. Lifetime Data Anal 8:335-348, 2002
20. National Cancer Institute: Cancer Therapy Evaluation Program Website. http://ctep.cancer.gov/forms/CTCAEv3.pdf
21. Milano MT, Katz AW, Muhs AG, et al: A prospective pilot study of curative-intent stereotac- tic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112:650-658, 2008
22. Park C, Papiez L, Zhang S, et al: Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70:847-852, 2008
23. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006
24. Hoyer M, Roed H, Hansen AT, et al: Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45:823-830, 2006
25. Mendez-Romero A, Wunderink W, Hussain SM, et al: Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 45:831-837, 2006
26. Dunlap N, Biederman G, Yang W, et al: Chest wall volume receiving more than 30 Gy predicts risk of severe pain and/or rib fracture after lung SBRT. Int J Radiat Oncol Biol Phys 72, 2008 (suppl 36)